Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > To be persuasive, we must be believable ....

<< Previous

Bullboard Posts

Next >>

Comment by Duster340on Nov 18, 2022 1:27pm

102 Views

Post# 35110957

RE:To be persuasive, we must be believable ....

davgro wrote: This post speaks for itself.

https://stockhouse.com/companies/bullboard?symbol=t.byl&postid=35110742

To be persuasive, we must be believable;

to be believable, we must be credible; to be credible, we must be truthful.

— Edward R. Murrow

davgro is none of the above, he is a proven liar he respond directly to my post on the NDVA board, when he said i was on ignore, flat out lie. so that eliminates credible, believable and truthful. most have you on ignore so the eliminates persuasive. lol

<< Previous

Bullboard Posts

Next >>

ArcStone-Kingswood Growth Summit 2024: A premier growth conference